Cassava Sciences reported $1.17M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Abbott USD 106M 28M Mar/2026
Biogen USD 37.9M 700K Mar/2026
Cara Therapeutics USD 347K 74K Mar/2025
Cassava Sciences USD 1.17M 47K Sep/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Geron USD 3.42M 624K Mar/2026
J&J USD 2.27 0.13 Jun/2026
Merck USD 35M 34M Mar/2026
Novavax USD 303K 27K Dec/2021
Pfizer USD -0.04 115M Jun/2026